Researchers described what they believe to be the first case of SMA type 4 presenting with a false enlargement of a muscle in ...

Women with spinal muscular atrophy (SMA) can experience successful pregnancies and give birth to healthy babies when ...

Columnist Jasmine Ramos explains her complicated feelings surrounding widespread coverage of a celebrity's SMA diagnosis ...

A test using a zebrafish model helped clinicians rule out SMA in two children, showing its potential use to clarify genetic ...

Columnist Sherry Toh details her recent visit to Universal Studios Singapore, where she noticed a gap between accessibility ...

Winter is columnist Connie Chandler's least favorite season, so her survival guide includes bundling up and large gatherings ...

A case report shows a baby with SMA met typical motor milestones at 10 months after a planned early C-section helped ...

For columnist Kevin Schaefer, the character arc of Dustin in "Stranger Things" is a reminder that feeling stuck is part of ...

Columnist Helen Baldwin recalls the surprising news of a new baby in the late 1990s, followed by a devastating SMA diagnosis.

FDA approved Itvisma, a one-time gene therapy for SMA patients ages 2 and older. Itvisma restores SMN protein, improving motor function and reducing treatment burden. A Novartis executive says the ...

SMA children frequently develop musculoskeletal problems such as scoliosis and hip dislocations, and new treatments are needed, per a study.

A gene therapy candidate extended survival in a mouse model of SMARD1, supporting its testing in a clinical trial for this rare form of SMA.